LAT1 was markedly more overexpressed than LAT2, and more so in PHEO (with 15.1- and 4.1-fold increases, respectively) than in MTC (with 9.9- and 4.1-fold increases, respectively). The gene discussed is LAT2; the disease is medullary thyroid gland carcinoma.